The phosphoprotein phosphatase family of Ser/Thr phosphatases as principal targets of naturally occurring toxins

References

• Ali A, Zhang J, Bao SD, Liu I, Otterness D, Dean NM, Abraham RT, Wang XF. (2004). Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation. Genes Dev 18:249–254.
   PubMed Web of Science ®Google Scholar
• Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T. (2004). Protein tyrosine phosphatases in the human genome. Cell 117:699–711.
   PubMed Web of Science ®Google Scholar
• Ammosova T, Jerebtsova M, Beullens M, Lesage B, Jackson A, Kashanchi F, Southerland W, Gordeuk VR, Bollen M, Nekhai S. (2005). Nuclear targeting of protein phosphatase-1 by HIV-1 Tat protein. J Biol Chem 280:36364–36371.
   PubMedGoogle Scholar
• Amorim A, Vasconcelos V. (1999). Dynamics of microcystins in the mussel Mytilus galloprovincialis. Toxicon 37:1041–1052.
   PubMed Web of Science ®Google Scholar
• An J, Carmichael WW. (1994). Use of a colorimetric protein phosphatase inhibition assay and enzyme linked immunosorbent assay for the study of microcystins and nodularins. Toxicon 32:1495–1507.
   PubMed Web of Science ®Google Scholar
• Andreeva AV, Kutuzov MA. (1999). RdgC/PP5-related phosphatases: Novel components in signal transduction. Cell Signal 11:555–562.
   PubMed Web of Science ®Google Scholar
• Andreeva AV, Kutuzov MA. (2001). PPP family of protein Ser/Thr phosphatases: Two distinct branches? Mol Biol Evol 18:448–452.
   PubMed Web of Science ®Google Scholar
• Archambault J, Chambers RS, Kobor MS, Ho Y, Cartier M, Bolotin D, Andrews B, Kane CM, Greenblatt J. (1997). An essential component of a C-terminal domain phosphatase that interacts with transcription factor IIF in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 94:14300–14305.
   PubMed Web of Science ®Google Scholar
• Bastians H, Ponstingl H. (1996). The novel human protein serine/threonine phosphatase 6 is a functional homologue of budding yeast Sit4p and fission yeast ppe1, which are involved in cell cycle regulation. J Cell Sci 109:2865–2874.
   PubMed Web of Science ®Google Scholar
• Bertini I, Calderone V, Fragai M, Luchinat C, Talluri E. (2009). Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin. J Med Chem 52:4838–4843.
   PubMed Web of Science ®Google Scholar
• Bialojan C, Takai A. (1988). Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem J 256:283–290.
   PubMed Web of Science ®Google Scholar
• Bialy L, Waldmann H. (2004). Total synthesis and biological evaluation of the protein phosphatase 2A inhibitor cytostatin and analogues. Chem Eur J 10:2759–2780.
   PubMed Web of Science ®Google Scholar
• Blatch GL, Lassle M. (1999). The tetratricopeptide repeat: A structural motif mediating protein-protein interactions. Bioessays 21:932–939.
   PubMed Web of Science ®Google Scholar
• Boger DL, Ichikawa S, Zhong W. (2001). Total synthesis of fostriecin (CI-920). J Am Chem Soc 123:4161–4167.
   PubMed Web of Science ®Google Scholar
• Boritzki TJ, Wolfard TS, Besserer JA, Jackson RC, Fry DW. (1988). Inhibition of type II topoisomerase by fostriecin. Biochem Pharmacol 37:4063–4068.
   PubMed Web of Science ®Google Scholar
• Ceulemans H, Bollen M. (2004). Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol Rev 84:1–39.
   PubMed Web of Science ®Google Scholar
• Chen J, Peterson RT, Schreiber SL. (1998). Alpha 4 associates with protein phosphatases 2A, 4, and 6. Biochem Biophys Res Commun 247:827–832.
   PubMed Web of Science ®Google Scholar
• Chen MS, Silverstein AM, Pratt WB, Chinkers M. (1996). The tetratricopeptide repeat domain of protein phosphatase 5 mediates binding to glucocorticoid receptor heterocomplexes and acts as a dominant negative mutant. J Biol Chem 271:32315–32320.
   PubMed Web of Science ®Google Scholar
• Chen MX, Cohen PTW. (1997). Activation of protein phosphatase 5 by limited proteolysis or the binding of polyunsaturated fatty acids to the TPR domain. FEBS Lett 400:136–140.
   PubMed Web of Science ®Google Scholar
• Chen MX, McPartlin AE, Brown L, Chen YH, Barker HM, Cohen PTW. (1994). A novel human protein serine/threonine phosphatase, which possesses 4 tetratricopeptide repeat motifs and localizes to the nucleus. EMBO J 13:4278–4290.
   PubMed Web of Science ®Google Scholar
• Chen X-C, Kihara T, Ying X, Uramoto M, Osada H, Kusakabe H, Wang B-N, Kobayashi Y, Ko K, Yamaguchi I, Shen Y-C, Isono K. (1989). A new antibiotic, tautomycetin. J Antibiot 42:141–144.
   PubMed Web of Science ®Google Scholar
• Chen X-C Ubukata, M, Isono K. (1990). The structure of tautomycetin, a dialkylmaleic anhydride antibiotic. J Antibiot 43:890–896.
   PubMed Web of Science ®Google Scholar
• Chinkers M. (1994). Targeting of a distinctive protein-serine phosphatase to the protein kinase-like domain of the atrial-natriuretic-peptide receptor. Proc Natl Acad Sci U S A 91:11075–11079.
   PubMed Web of Science ®Google Scholar
• Chinkers M. (2001). Protein phosphatase 5 in signal transduction. Trends Endocrinol Metab 12:28–32.
   PubMed Web of Science ®Google Scholar
• Cohen P. (2000). The regulation of protein function by multisite phosphorylation—A 25 year update. Trends Biochem Sci 25:596–601.
   PubMed Web of Science ®Google Scholar
• Cohen P, Holmes CFB, Tsukitani Y. (1990). Okadaic acid—A new probe for the study of cellular regulation. Trends Biochem Sci 15:98–102.
   PubMed Web of Science ®Google Scholar
• Cohen PTW. (1997). Novel protein serine/threonine phosphatases: Variety is the spice of life. Trends Biochem Sci 22:245–251.
   PubMed Web of Science ®Google Scholar
• Cohen PTW, Philp A, Vazquez-Martin C. (2005). Protein phosphatase 4—From obscurity to vital functions. FEBS Lett 579:3278–3286.
   PubMed Web of Science ®Google Scholar
• Connor JH, Kleeman T, Barik S, Honkanen RE, Shenolikar S. (1999). Importance of the β12-β13 loop in protein phosphatase-1 catalytic subunit for inhibition by toxins and mammalian protein inhibitors. J Biol Chem 274:22366–22372.
   PubMed Web of Science ®Google Scholar
• Craig M, Luu HA, McCready TL, Williams D, Andersen RJ, Holmes CFB. (1996). Molecular mechanisms underlying the interaction of motuporin and microycystins with type-1 and type-2A protein phosphatases. Biochem Cell Biol 74:569–578.
   PubMed Web of Science ®Google Scholar
• Craig M, McCready TL, Luu HA, Smillie MA, Dubord P, Holmes CFB. (1993). Identification and characterization of hydrophobic microcystins in Canadian freshwater cyanobacteria. Toxicon 31:1541–1549.
   PubMed Web of Science ®Google Scholar
• Das AK, Cohen PTW, Barford D. (1998). The structure of the tetratricopeptide repeats of protein phosphatase 5: Implications for TPR-mediated protein-protein interactions. EMBO J 17:1192–1199.
   PubMed Web of Science ®Google Scholar
• Das AK, Helps NR, Cohen PTW, Barford D. (1996). Crystal structure of the protein serine/threonine phosphatase 2C at 2.0 angstrom resolution. EMBO J. 15:6798–6809.
   PubMed Web of Science ®Google Scholar
• Dawson RM. (1998). The toxicology of microcystins. Toxicon 36:953–962.
   PubMed Web of Science ®Google Scholar
• De Jong RS, De Vries EGE, Mulder NH. (1997). Fostriecin: A review of the preclinical data. Anti-Cancer Drugs 8:413–418.
   PubMed Web of Science ®Google Scholar
• Denu JM, Dixon JE. (1998). Protein tyrosine phosphatases: Mechanisms of catalysis and regulation. Curr Opin Chem Biol 2:633–641.
   PubMed Web of Science ®Google Scholar
• Egloff MP, Johnson DF, Moorhead G, Cohen PTW, Cohen P, Barford D. (1997). Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1. EMBO J. 16:1876–1887.
   PubMed Web of Science ®Google Scholar
• Eichhorn PJA, Creyghton MP, Bernards R. (2009). Protein phosphatase 2A regulatory subunits and cancer. Biochim Biophys Acta Rev Cancer 1795:1–15.
   PubMed Web of Science ®Google Scholar
• Eriksson JE, Grönberg L, Nygård S, Slotte JP, Meriluoto JAO. (1990). Hepatocellular uptake of 3H-dihydromicrocystin-LR, a cyclic peptide toxin. Biochim Biophys Acta 1025:60–66.
   PubMed Web of Science ®Google Scholar
• Evans DRH, Simon JA. (2001). The predicted β12-β13 loop is important for inhibition of PP2Acα by the antitumor drug fostriecin. FEBS Lett 498:110–115.
   PubMed Web of Science ®Google Scholar
• Farkas I, Dombradi V, Miskei M, Szabados L, Koncz C. (2007). Arabidopsis PPP family of serine/threonine phosphatases. Trends Plant Sci 12:169–176.
   PubMed Web of Science ®Google Scholar
• Favre B, Turowski P, Hemmings BA. (1997). Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J Biol Chem 272:13856–13863.
   PubMed Web of Science ®Google Scholar
• Fruman DA, Klee CB, Bierer BE, Burakoff SJ. (1992). Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci U S A 89:3686–3690.
   PubMed Web of Science ®Google Scholar
• Fry DW, Besserer JA, Boritzki TJ. (1984). Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system. Cancer Res 44:3366–3370.
   PubMed Web of Science ®Google Scholar
• Frydrychowski VA, Urbanek RA, Dounay AB, Forsyth CJ. (2001). Importance of the C28-C38 hydrophobic domain of okadaic acid for potent inhibition of protein serine-threonine phosphatases 1 and 2A. Bioorg Med Chem Lett 11:647–649.
   PubMed Web of Science ®Google Scholar
• Fujiki H, Suganuma M. (1993). Tumor promotion by inhibitors of protein phosphatases 1 and 2A: The okadaic acid class of compounds. Adv Cancer Res 61:143–194.
   PubMed Web of Science ®Google Scholar
• Fukuda H, Shima H, Vesonder RF, Tokuda H, Nishino H, Katoh S, Tamura S, Sugimura T, Nagao M. (1996). Inhibition of protein serine threonine phosphatases by fumonisin B-1, a mycotoxin. Biochem Biophys Res Commun 220:160–165.
   PubMed Web of Science ®Google Scholar
• Fushimi S, Furihata K, Seto H. (1989). Studies on new phosphate ester antifungal antibiotics phoslactomycins. II. Structure elucidation of phoslactomycins A to F. J Antibiot 42:1026–1036.
   PubMed Web of Science ®Google Scholar
• Gigena MS, Ito A, Nojima H, Rogers TB. (2005). A B56 regulatory subunit of protein phosphatase 2A localizes to nuclear speckles in cardiomyocytes. Am J Physiol Heart Circ Physiol 289 (1 58-1).
   PubMed Web of Science ®Google Scholar
• Goldberg J, Huang HB, Kwon YG, Greengard P, Nairn AC, Kuriyan J. (1995). Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1. Nature 376:745–753.
   PubMed Web of Science ®Google Scholar
• Griffith JP, Kim JL, Kim EE, Sintchak MD, Thomson JA, Fitzgibbon MJ, Fleming MA, Caron PR, Hsiao K, Navia MA. (1995). X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell 82:507–522.
   PubMed Web of Science ®Google Scholar
• Gupta V, Ogawa AK, Du X, Houk KN, Armstrong RW. (1997). A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A. J Med Chem 40:3199–3206.
   PubMed Web of Science ®Google Scholar
• Harada KI, Ogawa K, Matsuura K, Murata H, Suzuki M, Watanabe MF, Itezono Y, Nakayama N. (1990). Structural determination of geometrical isomers of microcystins LR and RR from cyanobacteria by two-dimensional NMR spectroscopic techniques. Chem Res Toxicol 3:473–481.
   PubMed Web of Science ®Google Scholar
• Hastie CJ, Borthwick EB, Morrison LF, Codd GA, Cohen PTW. (2005). Inhibition of several protein phosphatases by a non-covalently interacting microcystin and a novel cyanobacterial peptide, nostocyclin. Biochim Biophys Acta Gen Subj 1726:187–193.
   PubMed Web of Science ®Google Scholar
• Hastie CJ, Carnegie GK, Morrice N, Cohen PTW. (2000). A novel 50 kDa protein forms complexes with protein phosphatase 4 and is located at centrosomal microtubule organizing centres. Biochem J 347:845–855.
   PubMed Web of Science ®Google Scholar
• Hastie CJ, Cohen PTW. (1998). Purification of protein phosphatase 4 catalytic subunit: Inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters. FEBS Lett 431:357–361.
   PubMed Web of Science ®Google Scholar
• Helps NR, Brewis ND, Lineruth K, Davis T, Kaiser K, Cohen PTW. (1998). Protein phosphatase 4 is an essential enzyme required for organisation of microtubules at centrosomes in Drosophila embryos. J Cell Sci 111:1331–1340.
   PubMed Web of Science ®Google Scholar
• Hendrickx A, Beullens M, Ceulemans H, Den Abt T, Van Eynde A, Nicolaescu E, Lesage B, Bollen M. (2009). Docking motif-guided mapping of the interactome of protein phosphatase-1. Chem Biol 16:365–371.
   PubMed Web of Science ®Google Scholar
• Hill TA, Stewart SG, Gordon CP, Ackland SP, Gilbert J, Sauer B, Sakoff JA, McCluskey A. (2008). Norcantharidin analogues: Synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition. ChemMedChem 3:1878–1892.
   PubMed Web of Science ®Google Scholar
• Holmes CFB, Luu HA, Carrier F, Schmitz FJ. (1990). Inhibition of protein phosphatases-1 and -2A with acanthifolicin: Comparison with diarrhetic shellfish toxins and identification of a region on okadaic acid important for phosphatase inhibition. FEBS Lett 270:216–218.
   PubMed Web of Science ®Google Scholar
• Honkanen RE. (1993). Cantharidin, another natural toxin that inhibits the activity of serine threonine protein phosphatases type-1 and type-2a. FEBS Lett 330:283–286.
   PubMed Web of Science ®Google Scholar
• Honkanen RE, Dukelow M, Zwiller J, Moore RE, Khatra BS, Boynton AL. (1991). Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases. Mol Pharmacol 40:577–583.
   PubMed Web of Science ®Google Scholar
• Honkanen RE, Golden T. (2002). Regulators of serine/threonine protein phosphatases at the dawn of a clinical era. Curr Med Chem 9:2055–2075.
   PubMed Web of Science ®Google Scholar
• Huai Q, Kim HY, Liu Y, Zhao Y, Mondragon A, Liu JO, Ke H. (2002). Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes. Proc Natl Acad Sci U S A 99:12037–12042.
   PubMed Web of Science ®Google Scholar
• Huang HB, Horiuchi A, Goldberg J, Greengard P, Nairn AC. (1997). Site-directed mutagenesis of amino acid residues of protein phosphatase 1 involved in catalysis and inhibitor binding. Proc Natl Acad Sci U S A 94:3530–3535.
   PubMed Web of Science ®Google Scholar
• Huang SL, Shu LL, Easton J, Harwood FC, Germain GS, Ichijo H, Houghton PJ. (2004). Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity. J Biol Chem 279:36490–36496.
   PubMed Web of Science ®Google Scholar
• Huang XZ, Honkanen RE. (1998). Molecular cloning, expression, and characterization of a novel human serine/threonine protein phosphatase, PP7, that is homologous to Drosophila retinal degeneration C gene product (rdgC). J Biol Chem 273:1462–1468.
   PubMed Web of Science ®Google Scholar
• Huhn J, Jeffrey PD, Larsen K, Rundberget T, Rise F, Cox NR, Arcus V, Shi Y, Miles CO. (2009). A structural basis for the reduced toxicity of dinophysistoxin-2. Chem Res Toxicol 22:1782–1786.
   PubMed Web of Science ®Google Scholar
• Hunter T. (1995). Protein-kinases and phosphatases—The yin and yang of protein-phosphorylation and signaling. Cell 80:225–236.
   PubMed Web of Science ®Google Scholar
• Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, Fusetani N, Watabe S, Hashimoto K, Uemura D, Hartshorne DJ. (1989). Calyculin A and okadaic acid: Inhibitors of protein phosphatase activity. Biochem Biophys Res Commun 159:871–877.
   PubMed Web of Science ®Google Scholar
• Janssens V, Goris J. (2001). Protein phosphatase 2A: A highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 353:417–439.
   PubMed Web of Science ®Google Scholar
• Jin L, Harrison SC. (2002). Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin. Proc Natl Acad Sci U S A 99:13522–13526.
   PubMed Web of Science ®Google Scholar
• Jochimsen EM, Carmichael WW, An JS, Cardo DM, Cookson ST, Holmes CEM, Antunes MBD, de Melo DA, Lyra TM, Barreto VST, Azevedo S, Jarvis WR. (1998). Liver failure and death after exposure to microcystins at a hemodialysis center in Brazil. N Engl J Med 338:873–878.
   PubMed Web of Science ®Google Scholar
• Jones S, Kress D. (2007). Treatment of molluscum contagiosum and herpes simplex virus cutaneous infections. Cutis 79:11–17.
   PubMed Web of Science ®Google Scholar
• Ju J, Li W, Yuan Q, Peters NR, Hoffmann FM, Rajski SR, Osada H, Shen B. (2009). Functional characterization of ttmM unveils new tautomycin analogs and insight into tautomycin biosynthesis and activity. Org Lett 11:1639–1642.
   PubMed Web of Science ®Google Scholar
• Jung WH, Guyenne S, Riesco-Fagundo C, Mancuso J, Nakamura S, Curran DP. (2008). Confirmation of the stereostructure of (+)-cytostatin by fluorous mixture synthesis of four candidate stereoisomers. Angew Chem 47:1130–1133.
   Google Scholar
• Kamenski T, Heilmeier S, Meinhart A, Cramer P. (2004). Structure and mechanism of RNA polymerase IICTD phosphatases. Mol Cell 15:399–407.
   PubMed Web of Science ®Google Scholar
• Kang H, Sayner SL, Gross KL, Russell LC, Chinkers M. (2001). Identification of amino acids in the tetratricopeptide repeat and C-terminal domains of protein phosphatase 5 involved in autoinhibition and lipid activation. Biochemistry 40:10485–10490.
   PubMed Web of Science ®Google Scholar
• Kato Y, Fusetani N, Matsunaga S, Hashimoto K, Koseki K. (1988). Isolation and structure elucidation of calyculins B, C, and D, novel antitumor metabolites, from the marine sponge Discodermia calyx. J Org Chem 53:3930–3932.
   Web of Science ®Google Scholar
• Kawada M, Amemiya M, Ishizuka M, Takeuchi T. (1999). Differential induction of apoptosis in B16 melanoma and EL-4 lymphoma cells by cytostatin and bactobolin. Jpn J Cancer Res 90:219–225.
   PubMedGoogle Scholar
• Kelker MS, Page R, Peti W. (2009). Crystal structures of protein phosphatase-1 bound to nodularin-R and tautomycin: A novel scaffold for structure-based drug design of serine/threonine phosphatase inhibitors. J Mol Biol 385:11–21.
   PubMed Web of Science ®Google Scholar
• Kennelly PJ. (2003). Archaeal protein kinases and protein phosphatases: Insights from genomics and biochemistry. Biochem J 370:373–389.
   PubMed Web of Science ®Google Scholar
• Kissinger CR, Parge HE, Knighton DR, Lewis CT, Pelletier LA, Tempczyk A, Kalish VJ, Tucker KD, Showalter RE, Moomaw EW, Gastinel LN, Habuka N, Chen X, Maldonado F, Barker JE, Bacquet R, Villafranca JE. (1995). Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature 378:641–644.
   PubMed Web of Science ®Google Scholar
• Kita A, Matsunaga S, Takai A, Kataiwa H, Wakimoto T, Fusetani N, Isobe M, Miki K. (2002). Crystal structure of the complex between calyculin A and the catalytic subunit of protein phosphatase 1. Structure 10:715–724.
   PubMed Web of Science ®Google Scholar
• Kloeker S, Bryant JC, Strack S, Colbran RJ, Wadzinski BE. (1997). Carboxymethylation of nuclear protein serine/threonine phosphatase X. Biochem J 327:481–486.
   PubMed Web of Science ®Google Scholar
• Kloeker S, Wadzinski BE. (1999). Purification and identification of a novel subunit of protein serine/threonine phosphatase 4. J Biol Chem 274:5339–5347.
   PubMed Web of Science ®Google Scholar
• Kumar R, Musiyenko A, Oldenburg A, Adams B, Barik S. (2004). Post-translational generation of constitutively active cores from larger phosphatases in the malaria parasite, Plasmodium falciparum: Implications for proteomics. BMC Mol Biol 5:6.
   PubMed Web of Science ®Google Scholar
• Kutuzov MA, Solov’eva OV, Andreeva AV, Bennett N. (2002). Protein Ser/Thr phosphatases PPEF interact with calmodulin. Biochem Biophys Res Commun 293:1047–1052.
   PubMed Web of Science ®Google Scholar
• Lawhorn BG, Boga SB, Wolkenberg SE, Colby DA, Gauss CM, Swingle MR, Amable L, Honkanen RE, Boger DL. (2006). Total synthesis and evaluation of cytostatin, its C10–C11 diastereomers, and additional key analogues: Impact on PP2A inhibition. J Am Chem Soc 128:16720–16732.
   PubMed Web of Science ®Google Scholar
• Lewy DS, Gauss CM, Soenen DR, Boger DL. (2002). Fostriecin: Chemistry and biology. Curr Med Chem 9:2005–2032.
   PubMed Web of Science ®Google Scholar
• Li X, Virshup DM. (2002). Two conserved domains in regulatory B subunits mediate binding to the A subunit of protein phosphatase 2A. Eur J Biochem 269:546–552.
   PubMedGoogle Scholar
• Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. (2005). Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 22:1942–1950.
   PubMed Web of Science ®Google Scholar
• MacKeigan JP, Murphy LO, Blenis J. (2005). Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat Cell Biol 7:591–600.
   PubMed Web of Science ®Google Scholar
• Mackintosh C, Beattie KA, Klumpp S, Cohen P, Codd GA. (1990). Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatase-1 and phosphatase-2a from both mammals and higher-plants. FEBS Lett 264:187–192.
   PubMed Web of Science ®Google Scholar
• MacKintosh C, Klumpp S. (1990). Tautomycin from the bacterium Streptomyces verticillatus. Another potent and specific inhibitor of protein phosphatases 1 and 2A. FEBS Lett 277:137–140.
   PubMed Web of Science ®Google Scholar
• Mackintosh C, Mackintosh RW. (1994). Inhibitors of protein-kinases and phosphatases. Trends Biochem Sci 19:444–448.
   PubMed Web of Science ®Google Scholar
• MacKintosh RW, Dalby KN, Campbell DG, Cohen PTW, Cohen P, MacKintosh C. (1995). The cyanobacterial toxin microcystin binds covalently to cysteine-273 on protein phosphatase 1. FEBS Lett 371:236–240.
   PubMed Web of Science ®Google Scholar
• Manning G, Plowman GD, Hunter T, Sudarsanam S. (2002). Evolution of protein kinase signaling from yeast to man. Trends Biochem Sci 27:514–520.
   PubMed Web of Science ®Google Scholar
• Masuda T, Watanabe S, Amemiya M, Ishizuka M, Takeuchi T. (1995). Inhibitory effect of cytostatin on spontaneous lung metastases of B16-BL6 melanoma cells. J Antibiot 48:528–529.
   PubMed Web of Science ®Google Scholar
• Matsunaga S, Fujiki H, Sakata D, Fusetani N. (1991). Calyculins E, F, G, and H, additional inhibitors of protein phosphatases 1 and 2A, from the marine sponge Discodermia calyx. Tetrahedron 47:2999–3006.
   Google Scholar
• Matsuzawa SI. (1994). Thyrsiferyl 23-acetate is a novel specific inhibitor of protein phosphatase PP2A. FEBS Lett 356:272–274.
   PubMed Web of Science ®Google Scholar
• Mayer-Jaekel RE, Hemmings BA. (1994). Protein phosphatase 2A a ‘menage a trois.’; Trends Cell Biol 4:287–291.
   PubMedGoogle Scholar
• Maynes JT, Bateman KS, Cherney MM, Das AK, Luu HA, Holmes CFB, James MNG. (2001). Crystal structure of the tumor-promoter okadaic acid bound to protein phosphatase-1. J Biol Chem 276:44078–44082.
   PubMed Web of Science ®Google Scholar
• Maynes JT, Luu HA, Cherney MM, Andersen RJ, Williams D, Holmes CFB, James MNG. (2006). Crystal structures of protein phosphatase-1 bound to motuporin and dihydromicrocystin-LA: Elucidation of the mechanism of enzyme inhibition by cyanobacterial toxins. J Mol Biol 356:111–120.
   PubMed Web of Science ®Google Scholar
• Maynes JT, Perreault KR, Cherny MM, Luu HA, James MNG, Holmes CFB. (2004). Crystal structure and mutagenesis of a protein phosphatase-1:calcineurin hybrid elucidate the role of the beta12-beta13 loop in inhibitor binding. J Biol Chem 279:43198–43206.
   PubMed Web of Science ®Google Scholar
• McCluskey A, Sim ATR, Sakoff JA. (2002). Serine-threonine protein phosphatase inhibitors: Development of potential therapeutic strategies. J Med Chem 45:1151–1175.
   PubMed Web of Science ®Google Scholar
• Meinhart A, Kamenski T, Hoeppner S, Baumli S, Cramer P. (2005). A structural perspective of CTD function. Genes Dev 19:1401–1415.
   PubMed Web of Science ®Google Scholar
• Mitsuhashi S, Matsuura N, Ubukata M, Oikawa H, Shima H, Kikuchi K. (2001). Tautomycetin is a novel and specific inhibitor of serine/threonine protein phosphatase type 1, PP1. Biochem Biophys Res Commun 287:328–331.
   PubMed Web of Science ®Google Scholar
• Moed L, Shwayder TA, Chang MW. (2001). Cantharidin revisited: A blistering defense of an ancient medicine. Arch Dermatol 137:1357–1360.
   PubMedGoogle Scholar
• Moorhead GB, De Wever V, Templeton G, Kerk D. (2009). Evolution of protein phosphatases in plants and animals. Biochem J 417:401–409.
   PubMedGoogle Scholar
• Morita K, Saitoh M, Tobiume K, Matsuura H, Enomoto S, Nishitoh H, Ichijo H. (2001). Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J 20:6028–6036.
   PubMed Web of Science ®Google Scholar
• Mourtada-Maarabouni M, Kirkham L, Jenkins B, Rayner J, Gonda TJ, Starr R, Trayner I, Farzaneh F, Williams GT. (2003). Functional expression cloning reveals proapoptotic role for protein phosphatase 4. Cell Death Differ 10:1016–1024.
   PubMed Web of Science ®Google Scholar
• Murakami Y, Oshima Y, Yasumoto T. (1982). Identification of okadaic acid as a toxic component of a marine dinoflagellate Prorocentrum lima. Bull Japan Soc Sci Fish 48:69–72.
   Google Scholar
• Nam KY, Hiro M, Kimura S, Fujiki H, Imanishi Y. (1990). Permeability of a non-TPA-type tumor promoter, okadaic acid, through lipid bilayer membrane. Carcinogenesis 11:1171–1174.
   PubMed Web of Science ®Google Scholar
• Namikoshi M, Rinehart KL, Sakai R, Stotts RR, Dahlem AM, Beasley VR, Carmichael WW, Evans WR. (1992). Identification of 12 hepatotoxins from a homer lake bloom of the cyanobacteria Microcystis aeruginosa, Microcystis viridis, and Microcystis wesenbergii: Nine new microcystins. J Org Chem 57:866–872.
   Web of Science ®Google Scholar
• Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M. (2006). Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127:635–648.
   PubMed Web of Science ®Google Scholar
• Ortega-La Zaro JC, Del Mazo J. (2003). Expression of the B56delta subunit of protein phosphatase 2A and Mea1 in mouse spermatogenesis. Identification of a new B56Agamma subunit (B56Agamma4) specifically expressed in testis. Cytogenet Genome Res 103:345–351.
   PubMed Web of Science ®Google Scholar
• Pouria S, De Andrade A, Barbosa J, Cavalcanti RL, Barreto VTS, Ward CJ, Preiser W, Poon GK, Neild GH, Codd GA. (1998). Fatal microcystin intoxication in haemodialysis unit in Caruaru, Brazil. Lancet 352:21–26.
   PubMed Web of Science ®Google Scholar
• Prickett TD, Brautigan DL. (2006). The alpha 4 regulatory subunit exerts opposing allosteric effects on protein phosphatases PP6 and PP2A. J Biol Chem 281:30503–30511.
   PubMed Web of Science ®Google Scholar
• Quinn RJ, Taylor C, Suganuma M, Fujiki H. (1993). The conserved acid binding domain model of inhibitors of protein phosphatases 1 and 2A: Molecular modelling aspects. Bioorg Med Chem Lett 3:1029–1034.
   Web of Science ®Google Scholar
• Ramsey AJ, Chinkers M. (2002). Identification of potential physiological activators of protein phosphatase 5. Biochemistry 41:5625–5632.
   PubMed Web of Science ®Google Scholar
• Rantala A, Fewer DP, Hisbergues M, Rouhiainen L, Vaitomaa J, Borner T, Sivonen K. (2004). Phylogenetic evidence for the early evolution of microcystin synthesis. Proc Natl Acad Sci U S A 101:568–573.
   PubMed Web of Science ®Google Scholar
• Rinehart KL, Namikoshi M, Choi BW. (1994). Structure and biosynthesis of toxins from blue-green algae (cyanobacteria). J Appl Phycol 6:159–176.
   Web of Science ®Google Scholar
• Runnegar M, Berndt N, Kaplowitz N. (1995). Microcystin uptake and inhibition of protein phosphatases: Effects of chemoprotectants and self-inhibition in relation to known hepatic transporters. Toxicol Appl Pharmacol 134:264–272.
   PubMed Web of Science ®Google Scholar
• Runnegar M, Berndt N, Kong SM, Lee EYC, Zhang L. (1995). In vivo and in vitro binding of microcystin to protein phosphatases 1 and 2A. Biochem Biophys Res Commun 216:162–169.
   PubMed Web of Science ®Google Scholar
• Saitou N, Nei M. (1987). The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406–425.
   PubMed Web of Science ®Google Scholar
• Shan HB, Cai YC, Liu Y, Zeng WN, Chen HX, Fan BT, Liu XH, Xu ZL, Wang B, Xian LJ. (2006). Cytotoxicity of cantharidin analogues targeting protein phosphatase 2A. Anti-Cancer Drugs 17:905–911.
   PubMed Web of Science ®Google Scholar
• Shim J-H, Lee H-K, Chang, E-J, Chae W-J, Han, J-H, Han D-J, Morio T, Yang J-J, Bothwell A, Lee S-K. (2002). Immunosuppressive effects of tautomycetin in vivo and in vitro via T cell-specific apoptosis induction. Proc Natl Acad Sci U S A 99:10617–10622.
   PubMed Web of Science ®Google Scholar
• Shima H, Tohda H, Aonuma S, Nakayasu M, Depaoli-Roach AA, Sugimura T, Nagao M. (1994). Characterization of the PP2Aα gene mutation in okadaic acid-resistant variants of CHO-K1 cells. Proc Natl Acad Sci U S A 91:9267–9271.
   PubMed Web of Science ®Google Scholar
• Sinclair C, Borchers C, Parker C, Tomer K, Charbonneau H, Rossie S. (1999). The tetratricopeptide repeat domain and a C-terminal region control the activity of Ser/Thr protein phosphatase 5. J Biol Chem 274:23666–23672.
   PubMed Web of Science ®Google Scholar
• Stark MJR. (1996). Yeast protein serine/threonine phosphatases: Multiple roles and diverse regulation. Yeast 12:1647–1675.
   PubMed Web of Science ®Google Scholar
• Stefansson B, Brautigan DL. (2006). Protein phosphatase 6 subunit with conserved sit4-associated protein domain targets I kappa B epsilon. J Biol Chem 281:22624–22634.
   PubMed Web of Science ®Google Scholar
• Stefansson B, Ohama T, Daugherty AE, Brautigan DL. (2008). Protein phosphatase 6 regulatory subunits composed of ankyrin repeat domains. Biochemistry 47:1442–1451.
   PubMed Web of Science ®Google Scholar
• Stern A, Privman E, Rasis M, Lavi S, Pupko T. (2007). Evolution of the metazoan protein phosphatase 2C superfamily. J Mol Evol 64:61–70.
   PubMed Web of Science ®Google Scholar
• Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB. (2004). A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101:6062–6067.
   PubMed Web of Science ®Google Scholar
• Sugiyama Y, Ohtani II, Isobe M, Takai A, Ubukata M, Isono K. (1996). Molecular shape analysis and activity of tautomycin, a protein phosphatase inhibitor. Bioorg Med Chem Lett 6:3–8.
   Web of Science ®Google Scholar
• Suzuki T, Suzuki M, Furusaki A. (1985). Teurilene and thyrsiferyl 23-acetate, meso and remarkably cytotoxic compounds from the marine red alga Laurencia obtusa (Hudson) Lamouroux. Tetrahedron Lett 26:1329–1332.
   Web of Science ®Google Scholar
• Swingle M, Ni L, Honkanen RE. (2007). Small molecule inhibitors of ser/thr protein phosphatases: Specificity, use and common forms of abuse. Methods Mol Biol 365:23–38.
   PubMedGoogle Scholar
• Swingle MR, Amable L, Lawhorn BG, Buck SB, Burke CP, Ratti P, Fischer KL, Boger DL, Honkanen RE. (2009). Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and (β12-β13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors. J Pharmacol Exp Ther 331:45–53.
   PubMed Web of Science ®Google Scholar
• Swingle MR, Honkanen RE, Ciszak EM. (2004). Structural basis for the catalytic activity of human serine/threonine protein phosphatase-5. J Biol Chem 279:33992–33999.
   PubMed Web of Science ®Google Scholar
• Tachibana K, Scheuer PJ, Tsukitani Y, Kikuchi H, Van Engen D, Clardy J, Gopichand Y, Schmitz FJ. (1981). Okadaic acid, a cytotoxic polyether from two marine sponges of the genus Halichondria. J Am Chem Soc 103:2469–2471.
   Web of Science ®Google Scholar
• Tamura K, Dudley J, Nei M, Kumar S. (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596–1599.
   PubMed Web of Science ®Google Scholar
• Tautz L, Pellecchia M, Mustelin T. (2006). Targeting the PTPome in human disease. Expert Opin Ther Targets 10:157–177.
   PubMed Web of Science ®Google Scholar
• Terrak M, Kerff F, Langsetmo K, Tao T, Dominguez R. (2004). Structural basis of protein phosphatase 1 regulation. Nature 429:780–784.
   PubMed Web of Science ®Google Scholar
• Teruya T, Simizu S, Kanoh N, Osada H. (2005). Phoslactomycin targets cysteine-269 of the protein phosphatase 2A catalytic subunit in cells. FEBS Lett 579:2463–2468.
   PubMed Web of Science ®Google Scholar
• Tolstykh T, Lee J, Vafai S, Stock JB. (2000). Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits. EMBO J 19:5682–5691.
   PubMed Web of Science ®Google Scholar
• Tonks NK. (2006). Protein tyrosine phosphatases: From genes, to function, to disease. Nat Rev Mol Cell Biol 7:833–846.
   PubMed Web of Science ®Google Scholar
• Ubukata M, Cheng XC, Isono K. (1990). The structure of tautomycin, a regulator of eukaryotic cell growth. J Chem Soc Chem Commun xx:244–246.
   Google Scholar
• Ueno Y, Nagata S, Tsutsumi T, Hasegawa A, Watanabe MF, Park HD, Chen GC, Chen G, Yu SZ. (1996). Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay. Carcinogenesis 17:1317–1321.
   PubMed Web of Science ®Google Scholar
• Urban G, Golden T, Aragon IV, Cowsert L, Cooper SR, Dean NM, Honkanen RE. (2003). Identification of a functional link for the p53 tumor suppressor protein in dexamethasone-induced growth suppression. J Biol Chem 278:9747–9753.
   PubMed Web of Science ®Google Scholar
• Usui T, Marriott G, Inagaki M, Swarup G, Osada H. (1999). Protein phosphatase 2A inhibitors, phoslactomycins. effects on the cytoskeleton in NIH/3T3 cells. J Biochem 125:960–965.
   PubMed Web of Science ®Google Scholar
• Vander Mierde D, Scheuner D, Quintens R, Patel R, Song B, Tsukamoto K, Beullens M, Kaufman RJ, Bollen M, Schuit FC. (2007). Glucose activates a protein phosphatase-1-mediated signaling pathway to enhance overall translation in pancreatic beta-cells. Endocrinology 148:609–617.
   PubMed Web of Science ®Google Scholar
• Vasconcelos V, Oliveira S, Teles FO. (2001). Impact of a toxic and a non-toxic strain of Microcystis aeruginosa on the crayfish Procambarus clarkii. Toxicon 39:1461–1470.
   PubMed Web of Science ®Google Scholar
• Vasconcelos VM. (1995). Uptake and depuration of the heptapeptide toxin microcystin-LR in Mytilus galloprovincialis. Aquat Toxicol 32:227–237.
   Web of Science ®Google Scholar
• Wakimoto T, Matsunaga S, Takai A, Fusetani N. (2002). Insight into binding of calyculin A to protein phosphatase 1: Isolation of hemicalyculin A and chemical transformation of calyculin A. Chem Biol 9:309–319.
   PubMedGoogle Scholar
• Walsh AH, Cheng A, Honkanen RE. (1997). Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A. FEBS Lett 416:230–234.
   PubMed Web of Science ®Google Scholar
• Wang GS. (1989). Medical uses of mylabris in ancient China and recent studies. J Ethnopharmacol 26:147–162.
   PubMed Web of Science ®Google Scholar
• Wechsler T, Chen BPC, Harper R, Morotomi-Yano K, Huang BCB, Meek K, Cleaver JE, Chen DJ, Wabl M. (2004). DNA-PKcs function regulated specifically by protein phosphatase 5. Proc Natl Acad Sci U S A 101:1247–1252.
   PubMed Web of Science ®Google Scholar
• Xing Y, Xu YH, Chen Y, Jeffrey PD, Chao Y, Lin Z, Li Z, Strack S, Stock JB, Shi YG. (2006). Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins. Cell 127:341–353.
   PubMed Web of Science ®Google Scholar
• Xu L, Lam PKS, Chen J, Zhang Y, Harada K. (2000). Comparative study on in vitro inhibition of grass carp (Ctenopharyngodon idellus) and mouse protein phosphatases by microcystins. Environ Toxicol 15:71–75.
   Web of Science ®Google Scholar
• Xu YH, Xing YN, Chen Y, Chao Y, Lin Z, Fan E, Yu JW, Strack S, Jeffrey PD, Shi YG. (2006). Structure of the protein phosphatase 2A holoenzyme. Cell 127:1239–1251.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Katoh H, Mori K, Negishi M. (2002). G alpha and G alpha(13) interact with Ser/Thr protein phosphatase type 5 and stimulate its phosphatase activity. Curr Biol 12:1353–1358.
   PubMed Web of Science ®Google Scholar
• Yang J, Roe SM, Cliff MJ, Williams MA, Ladbury JE, Cohen PTW, Barford D. (2005). Molecular basis for TPR domain-mediated regulation of protein phosphatase. EMBO J 24:1–10.
   PubMed Web of Science ®Google Scholar
• Yang J, Wu J, Tan C, Klein PS. (2003). PP2A: B56E is required for Wnt/beta-catenin signaling during embryonic development. Development 130:5569–5578.
   PubMed Web of Science ®Google Scholar
• Yu SZ. (1995). Primary prevention of hepatocellular carcinoma. J Gastroenterol Hepatol 10:674–682.
   PubMed Web of Science ®Google Scholar
• Zeke T, Morrice N, Vazquez-Martin C, Cohen PTW. (2005). Human protein phosphatase 5 dissociates from heat-shock proteins and is proteolytically activated in response to arachidonic acid and the microtubule-depolymerizing drug nocodazole. Biochem J 385:45–56.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang Z, Long F, Lee EYC. (1996). Tyrosine-272 is involved in the inhibition of protein phosphatase-1 by multiple toxins. Biochemistry 35:1606–1611.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhao S, Long F, Zhang L, Bai G, Shima H, Nagao M, Lee EYC. (1994). A mutant of protein phosphatase-1 that exhibits altered toxin sensitivity. J Biol Chem 269:16997–17000.
   PubMed Web of Science ®Google Scholar
• Zhao SY, Sancar A. (1997). Human blue-light photoreceptor hCRY2 specifically interacts with protein serine/threonine phosphatase 5 and modulates its activity. Photochem Photobiol 66:727–731.
   PubMed Web of Science ®Google Scholar
• Zhou GF, Golden T, Aragon IV, Honkanen RE. (2004). Ser/Thr protein phosphatase 5 inactivates hypoxia-induced activation of an apoptosis signal-regulating kinase 1/MKK-4/JNK signaling cascade. J Biol Chem 279:46595–46605.
   PubMed Web of Science ®Google Scholar
• Zuo Z, Dean NM, Honkanen RE. (1998). Serine/threonine protein phosphatase type 5 acts upstream of p53 to regulate the induction of p21(WAF1/Cip1) and mediate growth arrest. J Biol Chem 273:12250–12258.
   PubMed Web of Science ®Google Scholar
• Zuo Z, Urban G, Scammell JG, Dean NM, McLean TK, Aragon I, Honkanen RE. (1999). Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. Biochemistry 38:8849–8857.
   PubMed Web of Science ®Google Scholar
• Zurawell RW, Chen HR, Burke JM, Prepas EE. (2005). Hepatotoxic cyanobacteria: A review of the biological importance of microcystins in freshwater environments. J Toxicol Environ Health B Crit Rev 8:1–37.
   PubMed Web of Science ®Google Scholar